Preference for CD4-guided versus continuous HARRT in Thailand

References

• Ananworanich , J. , Cheunyam , T. , Teeratakulpisarn , S. , Boyd , M. A. , Ruxrungtham , K. Lange , J. 2004 . Creation of a drug fund for post-clinical trial access to antiretrovirals . Lancet , 364 : 101 – 102 .
   PubMed Web of Science ®Google Scholar
• Ananworanich , J. , Gayet-Ageron , A. , Le Braz , M. , Prasithsirikul , W. , Chetchotisakd , P. Kiertiburanakul , S. 2006 . CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: Results of the Staccato randomised trial . Lancet , 368 : 459 – 465 .
   PubMed Web of Science ®Google Scholar
• Ananworanich , J. , Siangphoe , U. , Hill , A. , Cardiello , P. , Apateerapong , W. Hirschel , B. 2005 . Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: The HIV Netherlands Australia Thailand Research Collaboration 001.4 study . Journal of Acquired Immune Deficiency Syndromes , 39 : 523 – 529 .
   PubMed Web of Science ®Google Scholar
• Carr , A. 2003a . Cardiovascular risk factors in HIV-infected patients . Journal of Acquired Immune Deficiency Syndromes , 34 ( Suppl. 1 ) : S73 – S78 .
   PubMed Web of Science ®Google Scholar
• Carr , A. 2003b . HIV lipodystrophy: Risk factors, pathogenesis, diagnosis and management . AIDS , 17 ( Suppl. 1 ) : S141 – S148 .
   PubMed Web of Science ®Google Scholar
• Danel , C. , Moh , R. , Minga , A. , Anzian , A. , Ba-Gomis , O. Kanga , C. 2006 . CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): A randomised trial . Lancet , 367 : 1981 – 1989 .
   PubMed Web of Science ®Google Scholar
• El-Sadr , W.M. , Lundgren , J.D. , Neaton , J.D. , Gordin , F. , Abrams , D. Arduino , R.C. 2006 . CD4 + count-guided interruption of antiretroviral treatment . New England Journal of Medicine , 355 : 2283 – 2296 .
   PubMed Web of Science ®Google Scholar
• Henry , K. , Katzenstein , D. , Cherng , D.W. , Valdez , H. , Powderly , W. Vargas , M.B. 2006 . A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy + /− interleukin 2: Results of ACTG A5102 . Journal of Acquired Immune Deficiency Syndromes , 42 : 140 – 148 .
   PubMed Web of Science ®Google Scholar
• Hill , A. & Alcorn , K. ( 2003 , July ). What is the minimum cost of HAART? Paper presented at the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment [664], Paris, France .
   Google Scholar
• Maggiolo , F. , Ripamonti , D. , Gregis , G. , Quinzan , G. , Callegaro , A. and Suter , F. 2004 . Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: A controlled, prospective trial . AIDS , 18 : 439 – 446 .
   PubMed Web of Science ®Google Scholar
• Palella , F.J. Jr , Delaney , K.M. , Moorman , A.C. , Loveless , M.O. , Fuhrer , J. Satten , G. A. 1998 . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators . New England Journal of Medicine , 338 : 853 – 860 .
   PubMed Web of Science ®Google Scholar
• Tuldra , A. , Fumaz , C.R. , Ferrer , M.J. , Paredes , R. , Romeu , J. Ruiz , L. 2001 . Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads . AIDS , 15 : 1904 – 1906 .
   PubMed Web of Science ®Google Scholar